JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Clinical trial NCT05174585 · COMPLETED
Trial details
- NCT number
- NCT05174585
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2025-05-09
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.